Copia Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Copia Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Sell	3,196 -214	-6%	-$22.1K	0.21%	88
2026 Q1	$354K	Sell	3,410 -1,123	-25%	-$120K	0.24%	80
2025 Q4	$468K	Sell	4,533 -805	-15%	-$78.3K	0.33%	58
2025 Q3	$482K	Sell	5,338 -91	-2%	-$7.97K	0.36%	57
2025 Q2	$478K	Sell	5,429 -733	-12%	-$63.5K	0.4%	50
2025 Q1	$562K	Sell	6,162 -457	-7%	-$41.2K	0.52%	41
2024 Q4	$571K	Buy	+6,619	New	+$599K	0.54%	39

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Copia Wealth Management's PPH Position: Q2 2026 in Review

Copia Wealth Management reduced its VanEck Pharmaceutical ETF (PPH) stake by 6.3% in Q2 2026, selling an estimated $22.1K and leaving 3,196 shares worth $349K. The position accounts for 0.21% of the portfolio, ranked #88.

Copia Wealth Management first reported a position in PPH in Q4 2024 and has held it in 7 quarters since. The position peaked at $571K in Q4 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Copia Wealth Management held 3,196 shares of VanEck Pharmaceutical ETF worth $349K as of Q2 2026.
Copia Wealth Management sold 214 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $22.1K.
VanEck Pharmaceutical ETF made up 0.21% of Copia Wealth Management's portfolio in Q2 2026, its #88 holding.
Copia Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q4 2024 and has held it in 7 quarters since.
Copia Wealth Management's VanEck Pharmaceutical ETF position peaked at $571K in Q4 2024.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Copia Wealth Management's 13F filing for Q2 2026, filed 18 Aug 2026.